Aptinyx

Aptinyx

Aptinyx, a spin-out of Naurex Pharmaceuticals, is focused on the development of novel drugs to treat neurological disorders. The company is building a pipeline of compounds that modulate the brain’s N-methyl-D-aspartate (NMDA) receptor for indications such as neuropathic pain, traumatic brain injury, Parkinson’s Disease and post-traumatic stress disorder.

<< Portfolio